Zdrowie i gospodarka · 01/02/2023

FDA Announces Draft Guidance for Lyme Disease Treatment

The Food and Drug Administration (FDA) has released a draft guidance to help pharmaceutical companies develop effective treatments for early Lyme disease, specifically the EM form, which is characterized by erythema migrans.